A detailed history of Resolute Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Resolute Financial, LLC holds 4,679 shares of ABBV stock, worth $953,907. This represents 0.64% of its overall portfolio holdings.

Number of Shares
4,679
Previous 4,386 6.68%
Holding current value
$953,907
Previous $589,000 28.35%
% of portfolio
0.64%
Previous 0.56%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $40,524 - $48,599
293 Added 6.68%
4,679 $756,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $1,342 - $1,539
10 Added 0.23%
4,386 $589,000
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $25,322 - $32,192
184 Added 4.39%
4,376 $670,000
Q1 2022

Apr 15, 2022

SELL
$131.98 - $163.75 $59,918 - $74,342
-454 Reduced 9.77%
4,192 $680,000
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $499,119 - $631,530
4,646 New
4,646 $629,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Resolute Financial, LLC Portfolio

Follow Resolute Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resolute Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resolute Financial, LLC with notifications on news.